The Healthcare Technology Report is pleased to announce the Top 25 Women Leaders in Healthcare Software of 2022. The awardees on this year’s list are among the most accomplished women in the healthcare technology industry. These leaders represent companies that provide solutions across a wide range of areas, from connected care to clinical software, ambulatory practices, cost containment, and beyond. They direct their companies from a variety of positions, from CEO to CTO, Chief Medical Officer to Chief Customer Officer, but what they have in common is their track record of leading their teams in producing exceptional results.
"Angela Losacco is the Senior Vice President of Global Sales for WhizAI, an AI-powered analytics platform purpose-built for healthcare and life sciences. WhizAI is on a mission to deliver contextual, conversational and dynamically generated insights directly into the hands of business users. Late last year one of its clients - a top 3 global pharma - was named as a finalist in Gartner’s Eye on Innovation Awards. WhizAI also announced it raised $8M in Series A financing and will use the capital to expand its team across the globe investing in sales and marketing.
Since joining WhizAI in January of 2022, Angela has been responsible for building the go-to-market functions. She leads WhizAI in rapidly growing and scaling the North American and European sales teams, developing and executing strategies to accelerate revenue growth and expand their increasing base of top pharmaceutical customers. Prior to joining WhizAI, Angela held leadership roles at Initiate Systems and IBM where she was responsible for data management and analytics product portfolios on a global basis. Most recently, she was the Vice President of Sales with Collibra where she was responsible for driving revenue growth 50% year over year in their North American markets which included their healthcare sector team. Angela received both her Finance degree and Master of Business Administration degree from Loyola University of Chicago." - The Healthcare Technology Report
In addition, as President of PointClickCare, Julieann Esper Rainville has launched several new business units that have become key drivers of company growth. Senior Vice President of Product Andrea Kowalski spearheaded the development of Kareo’s integrated telehealth solution, helping increase provider adoption by 40%. And under Neeraj Isaac’s leadership as Co-Founder and Chief Technology Officer, Hallmark Healthcare Solutions has brought multiple cloud-based solutions to market, including a patented provider compensation solution she co-created.
Hundreds of women were nominated for this year’s list. Each nominee was evaluated based on the scope of her experience, professional milestones achieved, and contributions to her organization and the broader healthcare industry. Please join us in celebrating The Top 25 Women Leaders in Healthcare Software of 2022.
People also viewed
Customer Centricity and Digital Experiences which are Redefining Pharma
It is no secret that the pharmaceutical industry has historically flourished from blockbuster products with substantial brand equity, favorable pricing
Awash in Data, Yet Starving for Insights? Transform Life Sciences Commercial Teams with Augmented Analytics
Personalized communication is something the HCPs have come to expect. To do that, pharma sales reps need to know their customers well. In order to know the customer well, they need data. Enterprise pharma companies, however, have many data resources and lots of data at their disposal. In fact, there is a data explosion. So what do you do?
Readiness of Augmented Analytics for Life Sciences Commercial Teams
Demand for smart, agile, and near-instant commercial analytics in Pharma is rising. More contextual, continuous, and connected data and analytics are required to respond to more complex and uncertain business decisions.
Adding Up Data Analytics Total Cost of Ownership (TCO) and How to Lower It
High data analytics expenditures don’t have to be a cost of doing business for life sciences companies. WhizAI lowers total cost of ownership (TCO) while making data insights more accessible to business users. Traditionally, data analytics TCO has been a significant expense for life sciences organizations.
Transforming Life Sciences Commercial Function with AI and Augmented Analytics
In this whitepaper, sponsored by WhizAl, Everest Group explores the business case and profound impact Al and Augmented Analytics can have on the life sciences commercial function across various use cases in Sales, Marketing, and Market Access. They examine what top pharma enterprises are looking for in an augmented analytics tool, a roadmap for how to get started, and a blueprint for adoption.
Augmented Analytics is “On the Rise” on Gartner’s 2022 Hype Cycle for Life Science Commercial Operations
The Gartner® 2022 Hype Cycle™ for Life Science Commercial Operations introduces a new category, Augmented Analytics, this year. WhizAI is listed as a sample vendor in the Augmented Analytics category in this Hype Cycle. This summary report covers the following highlights.
Why Domain Expertise Is Essential for Life Science Analytics
Domain expertise matters. Consider this: Enterprises choose transportation and logistics companies that have created the specific types of services they need. Businesses seek professional services with experience in their industries and look for consultants with good track records in their markets. However, remember that domain expertise benefits extend to analytics platforms, particularly those deployed for life sciences.